Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 5, 2004, Pages 479-485

  Gómez De Segura, Ignacio A ^a   Valderrábano, Santiago ^a   Vázquez, Isabel ^a   Vallejo Cremades, María T ^a   Gómez García, Lourdes ^a   Sánchez, Miriam ^a   De Miguel, Enrique ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

5 fluorouracil; Chemotherapy; DHA; Dietary protein; Docosahexaenoic acid; Enteritis; Growth hormone

Indexed keywords

DOCOSAHEXAENOIC ACID; FLUOROURACIL; GROWTH HORMONE; PLACEBO; POLYUNSATURATED FATTY ACID; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEEDING; HORMONE ACTION; INTESTINE INJURY; INTESTINE MUCOSA; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DIET; RAT; STANDARDIZATION;

ANIMALS; APOPTOSIS; BACTERIAL TRANSLOCATION; CELL DIVISION; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FLUOROURACIL; HUMAN GROWTH HORMONE; INTESTINAL ABSORPTION; INTESTINES; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 2342540410     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200405000-00008     Document Type: Article

References (44)

1. Bai MX, Jiang ZM, Liu YW, Wang WT, Li DM, Wilmore DW. Effects of alanyl-glutamine on gut barrier function. Nutrition 1998; 12:793-796.
2. Klimberg VS, Nwokedi E, Hutchins LF, Pappas AA, Lang NP, Broadwater JR, et al. Glutamine facilitates chemotherapy while reducing toxicity. J Parenter Enteral Nutr 1992; 16:83S-87S.
3. Shou J, Lieberman MD, Hofmann K, Leon P, Redmond HP, Davies H, Daly JM. Dietary manipulation of methotrexate-induced enterocolitis. J Parenter Enteral Nutr 1991; 15:307-312.
4. Torosian MH, Mullen JL, Miller EE, Zinnser KR, Buzby GP. Reduction of methotrexate toxicity with improved nutritional status in tumor-bearing animals. Cancer 1988; 61:1731-1735.
5. Kollman KA, Lien EL, Vanderhoof JA. Dietary lipids influence intestinal adaptation after massive bowel resection. J Pediatr Gastroenterol Nutr 1999; 28:41-45.
6. Tsai WS, Nagawa H, Kaizaki S, Tsuruo T, Muto T. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 1998; 33:206-212.
7. Kafrawy O, Zerouga M, Stillwell W, Jenski LJ. Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids. Cancer Lett 1998; 132:23-29.
8. Calviello G, Palozza P, Piccioni E, Maggiano N, Frattucci A, Franceschelli P, Bartoli GM. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 1998; 75:699-705.
9. Timmer B, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR. Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Natl Cancer Inst 1989; 81:1069-1075.
10. Horie T, Nakamaru M, Masubuchi Y. Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sci 1998; 62:1333-1338.
11. Vagianos C, Karatzas T, Scopa CO, Panagopoulos C, Tsoni I, Spiliopoulou I, Kalfarentzos F. Neurotensin reduces microbial translocation and improves intestinal mucosa integrity after abdominal radiation. Eur Surg Res 1992; 24:77-83.
12. Howarth GS, Fraser R, Frisby CL, Schirmer MB, Yeoh EK. Effects of insulin-like growth factor-I administration on radiation enteritis in rats. Scand J Gastroenterol 1997; 32:1118-1124.
13. Howarth GS, Cool JC, Bourne AJ, Ballard FJ, Read LC. Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotraxate. Growth Factors 1998; 15:279-292.
14. Petschow BW, Carter DL, Hutton GD. Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats. J Parenter Enteral Nutr 1993; 17:49-58.
15. Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1996; 58:933-939.
16. Chu KU, Higashide S, Evers BM, Rajaraman S, Ishizuka J, Townsend CMJ, Thompson JC. Bombesin improves survival from methotrexate-induced enterocolitis. Ann Surg 1994; 220:570-576.
17. Gomez de Segura IA, Prieto I, Grande AG, Garcia P, Guerra A, Mendez J, De-Miguel E. Growth hormone reduces mortality and bacterial translocation in irradiated rats. Acta Oncol 1998; 37:179-185.
18. Ortega M, Gomez de Segura IA, Lopez JM, Ladron de Guevara MC, De-Miguel E. Growth hormone plus a hyperproteic diet effects on methotrexate-induced injury in rat intestines. Acta Oncol 2001; 40:622-628.
19. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-497.
20. Vazquez I, Gomez de Segura IA, Grande AG, Escribano A, Gonzalez-Gancedo P, Gomez A, Diez R, De-Miguel E. Protective effect of enriched diet plus growth hormone administration on radiation-induced intestinal injury and on its evolutionary pattern in the rat. Dig Dis Sci 1999; 44:2350-2358.
21. Zhang W, Frankel WL, Bain A, Choi D, Klurfeld DM, Rombeau JL. Glutamine reduces bacterial translocation after small bowel transplantation in cyclosporine-treated rats. J Surg Res 1995; 58:159-164.
22. Carlson SE, Montalto MB, Ponder DL, Werkman SH, Korones SB. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr Res 1998; 44:491-498.
23. Dowling RH. Small bowel adaptation and its regulation. Scand J Gastroenterol 1982; 17:53-74.
24. Vanderhoof JA, Blackwood DJ, Mohammadpour H, Park JH. Effect of oral supplementation of glutamine on small intestinal mucosal mass following resection. J Am Coll Nutr 1992; 11:223-227.
25. Wilmore DW. Glutamine and the gut. Gastroenterology 1994; 107:1885-1886.
26. Wiren M, Magnusson KE, Larsson J. Enteral glutamine increases growth and absorptive capacity of intestinal mucosa in the malnourished rat. Scand J Gastroenterol 1995; 30:146-152.
27. Souba WW, Klimberg VS, Copeland EM. Glutamine nutrition in the management of radiation enteritis. J Parenter Enteral Nutr 1990; 14:106S-108S.
28. Scott TE, Moellman JR. Intravenous glutamine fails to improve gut morphology after radiation injury. J Parenter Enteral Nutr 1992; 16:440-444.
29. Wiseman JS, Senagore AJ, Chaudry IH. Methods to prevent colonic injury in pelvic radiation. Dis Colon Rectum 1994; 37:1090-1094.
30. Akbar M, Kim HY. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 2002; 82:655-665.
31. Yano M, Kishida E, Iwasaki M, Kojo S, Masuzawa Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J Nutr 2000; 130:1095-1101.
32. Gee JM, Watson M, Matthew JA, Rhodes M, Speakman CJ, Stebbings WS, Johnson IT. Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics. J Nutr 1999; 129:1862-1865.
33. Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapop-totic effect. J Biol Chem 2000; 275:35 215-35 223.
34. Calviello G, Palozza P, Maggiano N, Piccioni E, Franceschelli P, Frattucci A, et al. Cell proliferation, differentiation, and apoptosis are modified by n-3 polyunsaturated fatty acids in normal colonic mucosa. Lipids 1999; 34:599-604.
35. Geske FJ, Lieberman R, Strange R, Gerschenson LE. Early stages of p63-induced apoptosis are reversible. Cell Death Differ 2001; 8: 182-191.
36. Terano T, Tanaka T, Tamura Y, Kitagawa M, Higashi H, Saito Y, Hirai A. Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex. Biochem Biophys Res Commun 1999; 254:502-506.
37. Grande JP, Walker HJ, Holub BJ, Warner GM, Keller DM, Haugen JD, et al. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int 2000; 57:1027-1040.
38. Atkinson TG, Murray L, Berry DM, Ruthig DJ, Meckling GK. DHA feeding provides host protection and prevents fibrosarcoma-induced hyperlipidemia while maintaining the tumor response to araC in Fischer 344 rats. Nutr Cancer 1997; 28:225-235.
39. Mollerup S, Haugen A. Differential effect of polyunsaturated fatty acids on cell proliferation during human epithelial in vitro carcinogenesis: involvement of epidermal growth factor receptor tyrosine kinase. Br J Cancer 1996; 74:613-618.
40. Der S, Jonek JJ, Konecki J. The effect of 6-fluorouracil on the mitotic cycle and DNA synthesis in the epithelium of mouse small intestine. Folia Histochem Cytochem Krakow 1975; 13:21-35.
41. Wolf RF, Pearlstone DB, Newman E, Heslin MJ, Gonenne A, Burt ME, Brennan MF. Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg 1992; 216:280-288.
42. Demling R. Growth hormone therapy in critically ill patients. N Engl J Med 1999; 341:837-839.
43. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792.
44. Vanden Berghe G. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 2000; 342:135.